Category: Include on Menu
-
Bumble Agrees to $1.3 Billion All-Cash Acquisition by Ithaca Holdings at $6.05 Per Share
Bumble Inc. (NASDAQ:BMBL) has agreed to be acquired by Ithaca Holdings in a $1.3 billion transaction, offering shareholders a substantial premium and setting the dating platform on a path toward private ownership. Key Investor Takeaways Why BMBL Stock Is in Focus Bumble has entered into a definitive agreement to be acquired by Ithaca Holdings, marking…
-
Pinnacle Food Group Completes First Bench-Scale Fermentation of Recombinant Human Lactoferrin
Pinnacle Food Group (NASDAQ:PFAI) has confirmed recombinant human lactoferrin production using methanol-free fermentation technology, marking an early technical milestone in its precision fermentation programme and supporting further development toward potential commercial scale-up. Key Investor Takeaways Why PFAI Stock Is in Focus Pinnacle Food Group has completed its first controlled bench-scale fermentation of recombinant human lactoferrin…
-
BIO-key Appoints Stephen Morrow President of PortalGuard to Advance IAM Platform Growth
BIO-key International (NASDAQ:BKYI) has appointed cybersecurity executive Stephen Morrow to lead its flagship PortalGuard identity and access management platform, with a focus on expanding enterprise adoption and channel partnerships. Key Investor Takeaways Why BKYI Stock Is in Focus BIO-key International has appointed Stephen Morrow as President of PortalGuard, its principal IAM software platform, as the…
-
Dianthus Therapeutics Named to Fortune’s 2026 Best Workplaces in BioPharma List Amid Company Expansion
Dianthus Therapeutics (NASDAQ:DNTH) has earned its first place on Fortune’s Best Workplaces in BioPharma list, highlighting its employee culture as the clinical-stage biotechnology company continues expanding its workforce. Key Investor Takeaways Why DNTH Stock Is in Focus Dianthus Therapeutics has been included in Fortune’s 2026 Best Workplaces in BioPharma ranking for the first time, recognising…
-
Biodexa Reaches 100-Patient Enrollment Milestone in Phase 3 Serenta Trial as Key Analysis Timeline Accelerates
Biodexa Pharmaceuticals (NASDAQ:BDRX) has enrolled 100 patients in its registrational Phase 3 Serenta trial of eRapa for Familial Adenomatous Polyposis, with an interim futility analysis and database lock now potentially occurring earlier than originally anticipated. Key Investor Takeaways Why BDRX Stock Is in Focus Biodexa has reached a new recruitment milestone in its Phase 3…
-
AST SpaceMobile Shares Fall 5% as Piper Sandler Downgrades Stock on SpaceX Competition
AST SpaceMobile Inc. (NASDAQ:ASTS) shares declined approximately 5% in pre-market trading on Tuesday after Piper Sandler downgraded the satellite communications company, citing growing competition from SpaceX and potential constraints on satellite launch availability. Piper Sandler analyst Alexander Potter lowered his rating on AST SpaceMobile from Overweight to Neutral and reduced the firm’s price target to…
-
Enerflex Shares Rise 5% After Securing Over 1 GW Power Generation Contract for North American Data Centre
Enerflex Ltd. (NYSE:EFXT) shares advanced 5% in pre-market trading on Tuesday after the company announced a contract to supply more than one gigawatt (GW) of lower-emission natural gas-fired power generation equipment for a data centre development in North America. The contract expands Enerflex’s presence in the market for dedicated power infrastructure supporting artificial intelligence and…
-
Fermi Shares Jump 13.2% After AMD Credit Support Agreement Advances Texas AI Infrastructure Project
Fermi Inc. (NASDAQ:FRMI) shares surged 13.2% in pre-market trading on Tuesday after the company announced a credit support agreement with Advanced Micro Devices (NASDAQ:AMD) for the first phase of its Project Matador artificial intelligence infrastructure development in Texas. The agreement supports a customer lease covering 222 megawatts (MW) of gross power capacity at the Carson…
-
Cipher Digital Shares Fall 12% After Announcing $850 Million Convertible Debt Offering
Cipher Digital Inc. (NASDAQ:CIFR) shares declined 12% on Tuesday after the company announced plans to raise $850 million through a private offering of zero-interest convertible senior notes due in 2032, alongside a proposed exchange of existing debt for common stock. The financing is intended to support development of the company’s Barber Lake project, expansion of…
-
Raytheon Secures $729 Million in Counter-Drone Contracts for US Army, Qatar and Jordan
Raytheon, a subsidiary of RTX Corporation (NYSE:RTX), has secured contracts worth $729 million to supply counter-drone defence systems to the US Army, Qatar and Jordan, marking the first international sales of two of its key technologies. The agreements cover components of the Low, Slow, Small Unmanned Aircraft Integrated Defeat System (LIDS), which is designed to…